Skip to main content

SILVERARC CAPITAL MANAGEMENT, LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1816307 BOSTON, MA

Position in URGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$27,024,749
-$13,698,438 QoQ
Shares Held
1,503,045
-13.6% QoQ
Ownership
3.08%
of shares outstanding
% of Portfolio
3.18%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SILVERARC CAPITAL MANAGEMENT, LLC holds $784,099,188 across 56 Biotechnology names. URGN ranks #12 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in URGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $27,024,749 1,503,045
2025-12-31 $40,723,187 1,738,821
2025-09-30 $31,466,795 1,577,283
2025-06-30 $27,708,003 2,022,482
2025-03-31 $15,275,607 1,381,158
2024-12-31 $11,933,037 1,120,473
2024-09-30 $11,444,338 901,129
2024-06-30 $18,491,560 1,102,000
2024-03-31 $7,628,805 508,587
2023-12-31 $7,881,060 525,404
2023-09-30 $7,129,450 508,883